PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Ortho Evra, cont'd



"A federal caution about potentially life-threatening effects of Johnson & Johnson's Ortho Evra contraceptive patch has fanned the flames of what could become nationwide litigation," and lawyers are beginning to advertise heavily around the country for clients, reports the New Jersey Law Journal. We covered the unfolding story Nov. 15. The Well-Timed Period has more, as does MedGadget:

...some sloppy reporting has muddled the issue: It's not yet clear whether the patch's higher basal estrogen levels causes more adverse effects for women.

(emphasis in original). That's not stopping the rush to court, of course.

 

 


Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute
igorodetski@manhattan-institute.org

Katherine Lazarski
Press Officer,
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.